Document is current
Any future updates will be listed below
-
Authors
van den Kroonenberg, Daniel L. https://orcid.org/0000-0001-8448-4193
Delberghe, Florian
Jager, Auke
Postema, Arnoud W.
de Bie, Katelijne C. C.
Reitsma, Johannes B.
Zwart, Marije
Wijkstra, Hessel
Garrido-Utrilla, Anna
de Baaij, Joost
van Basten, Jean-Paul A.
van der Poel, Henk G.
Beerlage, Harrie P.
Mischi, Massimo
Oddens, Jorg R.
-
Funding
Funding for this research was provided by:
AngioGenesis Analytics
European Innovation Council and Small and Medium-sized Enterprises Executive Agency
- License Information
-
More Information
Article History
Received: 3 July 2025
Revised: 10 September 2025
Accepted: 13 October 2025
First Online: 6 November 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is D. L. van den Kroonenberg.
: The authors of this manuscript declare relationships with the following companies: Arnoud W. Postema, Auke Jager, and Johannes B. Reitsma are scientific advisors for Angiogenesis Analytics, for which they receive compensation. Anna Garrido-Utrilla is a full-time employee of Angiogenesis Analytics. Harrie P. Beerlage is chief of the clinical board for Angiogenesis Analytics.
: Johannes B. Reitsma kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study, which explicitly included consent for both the training phase and the retrospective testing phase (the present study).
: Institutional Review Board approval was obtained.
: There is no overlap in patient population with previously published studies.
:
